Home >> Research Area >>PI3K/Akt/mTOR Signaling>>GSK-3>> GSK-3 inhibitor 1

GSK-3 inhibitor 1

CAS# 603272-51-1

GSK-3 inhibitor 1

Catalog No. BCC4126----Order now to get a substantial discount!

Product Name & Size Price Stock
GSK-3 inhibitor 1: 5mg Please Inquire In Stock
GSK-3 inhibitor 1: 10mg Please Inquire In Stock
GSK-3 inhibitor 1: 20mg Please Inquire Please Inquire
GSK-3 inhibitor 1: 50mg Please Inquire Please Inquire
GSK-3 inhibitor 1: 100mg Please Inquire Please Inquire
GSK-3 inhibitor 1: 200mg Please Inquire Please Inquire
GSK-3 inhibitor 1: 500mg Please Inquire Please Inquire
GSK-3 inhibitor 1: 1000mg Please Inquire Please Inquire
Related Products

Quality Control of GSK-3 inhibitor 1

Number of papers citing our products

Chemical structure

GSK-3 inhibitor 1

3D structure

Chemical Properties of GSK-3 inhibitor 1

Cas No. 603272-51-1 SDF Download SDF
PubChem ID 78357782 Appearance Powder
Formula C22H17ClFN5O2 M.Wt 437.85
Type of Compound N/A Storage Desiccate at -20°C
Solubility Soluble in DMSO
SMILES C1CN2C=C(C3=CC(=CC(=C32)CN1)F)C4=C(C(=O)NC4=O)C5=CN=C6N5C=CC=C6.Cl
Standard InChIKey CXXAOCQHGIGIBJ-UHFFFAOYSA-N
Standard InChI InChI=1S/C22H16FN5O2.ClH/c23-13-7-12-9-24-4-6-27-11-15(14(8-13)20(12)27)18-19(22(30)26-21(18)29)16-10-25-17-3-1-2-5-28(16)17;/h1-3,5,7-8,10-11,24H,4,6,9H2,(H,26,29,30);1H
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Biological Activity of GSK-3 inhibitor 1

DescriptionGSK-3 inhibitor 1 is an inhibitor of GSK-3.

References:
[1]. SOLUBILIZED COMPOSITIONS FOR CONTROLLED PROLIFERATION OF STEM CELLS / GENERATING INNER EAR HAIR CELLS USING GSK3 INHIBITORS: III. 20170252449 A1

GSK-3 inhibitor 1 Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

GSK-3 inhibitor 1 Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of GSK-3 inhibitor 1

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 2.2839 mL 11.4194 mL 22.8389 mL 45.6777 mL 57.0972 mL
5 mM 0.4568 mL 2.2839 mL 4.5678 mL 9.1355 mL 11.4194 mL
10 mM 0.2284 mL 1.1419 mL 2.2839 mL 4.5678 mL 5.7097 mL
50 mM 0.0457 mL 0.2284 mL 0.4568 mL 0.9136 mL 1.1419 mL
100 mM 0.0228 mL 0.1142 mL 0.2284 mL 0.4568 mL 0.571 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University

Background on GSK-3 inhibitor 1

GSK-3 inhibitor 1 is a potent GSK-3 inhibitor.

Featured Products
New Products
 

References on GSK-3 inhibitor 1

Efficacy of a novel, orally active GSK-3 inhibitor 6-Methyl-N-[3-[[3-(1-methylethoxy)propyl]carbamoyl]-1H-pyrazol-4-yl]pyridine-3-ca rboxamide in tau transgenic mice.[Pubmed:19698704]

Brain Res. 2009 Nov 3;1296:148-63.

Neurofibrillary tangles (NFTs) composed of hyperphosphorylated and aggregated tau are common pathological characteristics in Alzheimer's disease (AD) and other tauopathies. Aberrant tau phosphorylation is an early and pivotal event in the pathogenesis of tauopathies, and since GSK-3 is a key factor implicated in aberrant tau phosphorylation, GSK-3 inhibition is expected to suppress tauopathy disease progression. In the present study, we report the efficacy of a newly discovered small molecule GSK-3 inhibitor, 6-methyl-N-[3-[[3-(1-methylethoxy)propyl]carbamoyl]-1H-pyrazol-4-yl]pyridine-3-ca rboxamide (compound A), to inhibit tau phosphorylation and to reduce the amount of pathological aggregated tau in JNPL3 mice that overexpress a mutant form of human tau. Compound A is a highly potent and selective inhibitor of GSK-3 with an IC(50) of 2 nM, with at least 230-fold lower potency against 27 other kinases. Oral administration of compound A resulted in a significant reduction of tau phosphorylation at several GSK-3 directed sites. Furthermore, chronic oral administration of compound A markedly reduced aggregated tau in old JNPL3 mice. These results suggest that a novel, orally active GSK-3 inhibitor, compound A, has potency in the prevention of tau pathology.

9-cyano-1-azapaullone (cazpaullone), a glycogen synthase kinase-3 (GSK-3) inhibitor activating pancreatic beta cell protection and replication.[Pubmed:18345612]

J Med Chem. 2008 Apr 10;51(7):2196-207.

Recently, the serine/threonine kinase glycogen synthase kinase-3 (GSK-3) emerged as a regulator of pancreatic beta cell growth and survival. On the basis of the previous observation that GSK-3 inhibitors like 1-azakenpaullone promote beta cell protection and replication, paullone derivatives were synthesized including 1-aza-, 2-aza-, and 12-oxapaullone scaffolds. In enzymatic assays distinct 1-azapaullones were found to exhibit selective GSK-3 inhibitory activity. Within the series of 1-azapaullones, three derivatives stimulated INS-1E beta cell replication and protected INS-1E cells against glucolipotoxicity induced cell death. Cazpaullone (9-cyano-1-azapaullone), the most active compound in the protection assays, also stimulated the replication of primary beta cells in isolated rat islets. Furthermore, cazpaullone showed a pronounced transient stimulation of the mRNA expression of the beta cell transcription factor Pax4, an important regulator of beta cell development and growth. These features distinguish cazpaullone as a unique starting point for the development of beta cell regenerative agents which might be useful in the treatment of diabetes.

Description

GSK-3 inhibitor 1 is an inhibitor of GSK-3.

Keywords:

GSK-3 inhibitor 1,603272-51-1,Natural Products,GSK-3, buy GSK-3 inhibitor 1 , GSK-3 inhibitor 1 supplier , purchase GSK-3 inhibitor 1 , GSK-3 inhibitor 1 cost , GSK-3 inhibitor 1 manufacturer , order GSK-3 inhibitor 1 , high purity GSK-3 inhibitor 1

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: